Another potential therapeutic intervention in COPD entails modulating the dynamics of mitochondria, using specific compounds such as Dynamin-related protein 1 (Drp1) inhibitors and PTEN-induced kinase 1 (PINK1) activators. This evidence concerns the gene DNM1L and chronic obstructive pulmonary disease.